Michael F Berger
Michael F Berger
Verified email at mskcc.org
TitleCited byYear
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ...
Nature 483 (7391), 603-607, 2012
The mutational landscape of head and neck squamous cell carcinoma
N Stransky, AM Egloff, AD Tward, AD Kostic, K Cibulskis, A Sivachenko, ...
Science 333 (6046), 1157-1160, 2011
Comprehensive molecular characterization of clear cell renal cell carcinoma
CGAR Network
Nature 499 (7456), 43-49, 2013
The genomic complexity of primary human prostate cancer
MF Berger, MS Lawrence, F Demichelis, Y Drier, K Cibulskis, ...
Nature 470 (7333), 214-220, 2011
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto, K Wang, SR Downing, J He, ...
Nature biotechnology 31 (11), 1023, 2013
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling
N Wagle, C Emery, MF Berger, MJ Davis, A Sawyer, P Pochanard, ...
Journal of clinical oncology 29 (22), 3085, 2011
Diversity and complexity in DNA recognition by transcription factors
G Badis, MF Berger, AA Philippakis, S Talukder, AR Gehrke, SA Jaeger, ...
Science 324 (5935), 1720-1723, 2009
Punctuated evolution of prostate cancer genomes
SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ...
Cell 153 (3), 666-677, 2013
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ...
Nature medicine 23 (6), 703, 2017
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
W Toy, Y Shen, H Won, B Green, RA Sakr, M Will, Z Li, K Gala, S Fanning, ...
Nature genetics 45 (12), 1439, 2013
Melanoma genome sequencing reveals frequent PREX2 mutations
MF Berger, E Hodis, TP Heffernan, YL Deribe, MS Lawrence, ...
Nature 485 (7399), 502-506, 2012
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for …
DT Cheng, TN Mitchell, A Zehir, RH Shah, R Benayed, A Syed, ...
The Journal of molecular diagnostics 17 (3), 251-264, 2015
Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificities
MF Berger, AA Philippakis, AM Qureshi, FS He, PW Estep, ML Bulyk
Nature biotechnology 24 (11), 1429-1435, 2006
Genome sequencing identifies a basis for everolimus sensitivity
G Iyer, AJ Hanrahan, MI Milowsky, H Al-Ahmadie, SN Scott, ...
Science 338 (6104), 221-221, 2012
Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences
MF Berger, G Badis, AR Gehrke, S Talukder, AA Philippakis, ...
Cell 133 (7), 1266-1276, 2008
Inherited DNA-repair gene mutations in men with metastatic prostate cancer
CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ...
N Engl J Med 375, 443-453, 2016
Genome‐wide analysis of ETS‐family DNA‐binding in vitro and in vivo
GH Wei, G Badis, MF Berger, T Kivioja, K Palin, M Enge, M Bonke, ...
The EMBO journal 29 (13), 2147-2160, 2010
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing
N Wagle, MF Berger, MJ Davis, B Blumenstiel, M DeFelice, P Pochanard, ...
Cancer discovery 2 (1), 82-93, 2012
Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays
S Mukherjee, MF Berger, G Jona, XS Wang, D Muzzey, M Snyder, ...
Nature genetics 36 (12), 1331-1339, 2004
High-resolution DNA-binding specificity analysis of yeast transcription factors
C Zhu, KJRP Byers, RP McCord, Z Shi, MF Berger, DE Newburger, ...
Genome research 19 (4), 556-566, 2009
The system can't perform the operation now. Try again later.
Articles 1–20